Question explored with the scientific record
Conversation so far
- 1 Cancer is a immune response and not the only one
- 2 Triggered by infection, exactly so a infection is treated with antibiotics not seraquil
Answered on this page ↓
Triggered by infection, exactly so a infection is treated with antibiotics not seraquil
The short version: no. Antibiotics treat bacteria, not cancer, and Seroquel is a psychiatric drug with no role in either. Infection can nudge cancer risk, but that is not the same as infection being the cancer.
Your sentence has the logic backwards. An infection is treated with antibiotics because the antibiotic kills the bacterium. Cancer is your own cells dividing out of control, and an antibiotic has no target in a human cell. Seroquel (quetiapine) is an antipsychotic; nothing in this evidence gives it any anticancer role.
Infection does touch cancer, but as a risk factor and a promoter, not as the disease itself. Gum and gut bacteria can drive tumor-promoting signaling: P. gingivalis proteins push head and neck cancer cells toward invasion and chemotherapy resistance [1], and F. nucleatum is enriched in colorectal tumors [3]. In mice, metronidazole cut F. nucleatum and slowed tumor growth [3], and antibiotics partially calmed inflammation-driven colon cancer in a barrier-defect model [2]. That is a narrow, model-specific effect on bacteria-fueled inflammation, not a cancer cure.
| Claim | What the evidence shows |
|---|---|
| Antibiotics cure cancer | No. Mouse tumor slowing only, tied to specific bacteria [2][3] |
| Infection causes cancer | Promotes risk in some tissues, not the cause [1][3] |
| Seroquel treats cancer | Nothing in this evidence supports it |
The honest limit: these are mouse and tissue studies of bacterial promoters, not human trials of antibiotics as cancer treatment. Using antibiotics to "treat cancer" would also wreck the gut microbiome that helps keep tumors in check [3].
My call: antibiotics are for bacterial infections, not cancer, and Seroquel is irrelevant here. Confidence: high.
Sources used 3
-
Bacterial internalins exploit E-cadherin to promote head and neck tumor metastasis and drug resistance
Porphyromonas gingivalis secretes two internalin-like proteins, InlA and InlB, via the Type IX secretion system, that bind the Ec1 domain of human E-cadherin to reprogram epithelial signaling and promote EMT, metastasis, and chemoresistance in head and neck squamous cell carcino…
DOI: 10.64898/2026.04.20.719623 -
Hemidesmosome integrity protects the colon against colitis and colorectal cancer
This study demonstrates that intestinal epithelial cell detachment due to loss of α6β4 hemidesmosomes disrupts the epithelial barrier, triggers epithelial IL-18–driven inflammation and mucus-layer defects that permit bacterial translocation, and drives spontaneous colitis and co…
DOI: 10.1136/gutjnl-2015-310847 -
The gut microbiota in colorectal cancer: role in cytokine regulation, intestinal immune barrier dysfunction
This narrative review synthesizes evidence that gut microbiota dysbiosis promotes colorectal cancer through cytokine dysregulation and immune barrier disruption, highlighting mechanistic pathways and emerging microbiota-based therapeutic strategies.
DOI: 10.3389/fonc.2026.1866422